{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:27:43Z","timestamp":1794371263710,"version":"4.9.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0024718"],"award-info":[{"award-number":["NNF17OC0024718"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novo Nordisk Fonden,Denmark","award":["NNF19OC0055001"],"award-info":[{"award-number":["NNF19OC0055001"]}]},{"name":"Absalonfonden"},{"name":"Swedish Research Counsil","award":["#2018-02532"],"award-info":[{"award-number":["#2018-02532"]}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["#681712"],"award-info":[{"award-number":["#681712"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Research Council,European Union","award":["#101053962"],"award-info":[{"award-number":["#101053962"]}]},{"name":"Swedish State Support for Clinical Research","award":["#ALFGBG-71320"],"award-info":[{"award-number":["#ALFGBG-71320"]}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["#201809-2016862"],"award-info":[{"award-number":["#201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AD Strategic Fund and the Alzheimer's Association","award":["#ADSF-21-831376-C"],"award-info":[{"award-number":["#ADSF-21-831376-C"]}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["#FO2019-0228"],"award-info":[{"award-number":["#FO2019-0228"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 860197 (MIRIADE)"],"award-info":[{"award-number":["No 860197 (MIRIADE)"]}]},{"name":"European Union Joint Programme \u2013 Neurodegenerative Disease Research","award":["JPND2021-00694"],"award-info":[{"award-number":["JPND2021-00694"]}]},{"name":"UK Dementia Research Institute at UCL","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pathological cerebral conditions may manifest in altered composition of the cerebrospinal fluid (CSF). Although diagnostic CSF analysis seeks to establish pathological disturbances in the brain proper, CSF is generally sampled from the lumbar compartment for reasons of technical ease and ethical considerations. We here aimed to compare the molecular composition of CSF obtained from the ventricular versus the lumbar CSF compartments to establish a relevance for employing lumbar CSF as a proxy for the CSF bathing the brain tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      CSF was collected from 46 patients with idiopathic normal pressure hydrocephalus (iNPH) patients during their diagnostic workup (lumbar samples) and in connection with their subsequent CSF diversion shunt surgery (ventricular samples). The mass-spectrometry-based proteomic profile was determined in these samples and in addition, selected biomarkers were quantified with ELISA (S100B, neurofilament light (NfL), amyloid-\u03b2 (A\u03b2\n                      <jats:sub>40<\/jats:sub>\n                      , A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      ), and total tau (T-tau) and phosphorylated tau (P-tau) forms). The latter analysis was extended to include paired porcine samples obtained from the lumbar compartment and the cerebromedullary cistern closely related to the ventricles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total 1231 proteins were detected in the human CSF. Of these, 216 distributed equally in the two CSF compartments, whereas 22 were preferentially (or solely) present in the ventricular CSF and four in the lumbar CSF. The selected biomarkers of neurodegeneration and Alzheimer\u2019s disease displayed differential distribution, some with higher (S100B, T-tau, and P-tau) and some with lower (NfL, A\u03b2\n                      <jats:sub>40<\/jats:sub>\n                      , A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      ) levels in the ventricular compartment. In the porcine samples, all biomarkers were most abundant in the lumbar CSF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The overall proteomic profile differs between the ventricular and the lumbar CSF compartments, and so does the distribution of clinically employed biomarkers. However, for a range of CSF proteins and biomarkers, one can reliably employ lumbar CSF as a proxy for ventricular CSF if or a lumbar\/cranial index for the particular molecule has been established. It is therefore important to verify the compartmental preference of the proteins or biomarkers of interest prior to extrapolating from lumbar CSF to that of the ventricular fluid bordering the brain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-022-00405-0","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T22:02:45Z","timestamp":1674252165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Differential proteomic profile of lumbar and ventricular cerebrospinal fluid"],"prefix":"10.1186","volume":"20","author":[{"given":"Nina","family":"Rostgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Harboe","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Ottenheijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lylia","family":"Drici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Hviid","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Plomgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Gredal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Harding","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Gregers","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"MacAulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Juhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,21]]},"reference":[{"key":"405_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-022-01339-6","author":"R Hau\u00dfmann","year":"2022","unstructured":"Hau\u00dfmann R, Homeyer P, Brandt MD, Donix M. Prognostic and diagnostic value of cerebrospinal fluid analysis in neurodegenerative dementia diseases. Nervenarzt. 2022. https:\/\/doi.org\/10.1007\/s00115-022-01339-6.","journal-title":"Nervenarzt."},{"issue":"9","key":"405_CR2","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.3390\/ijms23094610","volume":"23","author":"J Doroszkiewicz","year":"2022","unstructured":"Doroszkiewicz J, Groblewska M, Mroczko B. Molecular biomarkers and their implications for the early diagnosis of selected neurodegenerative diseases. Int J Mol Sci. 2022;23(9):4610.","journal-title":"Int J Mol Sci"},{"issue":"Supplement","key":"405_CR3","first-page":"S111","volume":"65","author":"N Husain","year":"2022","unstructured":"Husain N, Husain A, Mishra S, Srivastava P. Liquid biopsy in CNS tumors: current status & future perspectives. Indian J Pathol Microbiol. 2022;65(Supplement):S111\u201321.","journal-title":"Indian J Pathol Microbiol"},{"issue":"7","key":"405_CR4","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1007\/s12035-022-02822-6","volume":"59","author":"HS Ghaith","year":"2022","unstructured":"Ghaith HS, Nawar AA, Gabra MD, Abdelrahman ME, Nafady MH, Bahbah EI, Ebada MA, Ashraf GM, Negida A, Barreto GE. A literature review of traumatic brain injury biomarkers. Mol Neurobiol. 2022;59(7):4141\u201358.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"405_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/ene.14655","volume":"28","author":"C Chen","year":"2021","unstructured":"Chen C, Hu C, Zhou W, Chen J, Shi Q, Xiao K, Wang Y, Dong XP. Calmodulin level is significantly increased in the cerebrospinal fluid of patients with sporadic Creutzfeldt-Jakob disease. Eur J Neurol. 2021;28(4):1134\u201341.","journal-title":"Eur J Neurol"},{"issue":"3","key":"405_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S1525-1578(10)60566-1","volume":"7","author":"A Abdulmawjood","year":"2005","unstructured":"Abdulmawjood A, Sch\u00f6nenbr\u00fccher H, B\u00fclte M. Novel molecular method for detection of bovine-specific central nervous system tissues as bovine spongiform encephalopathy risk material in meat and meat products. J Mol Diagn. 2005;7(3):368\u201374.","journal-title":"J Mol Diagn"},{"issue":"4","key":"405_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3988\/jcn.2022.18.4.401","volume":"18","author":"SA Park","year":"2022","unstructured":"Park SA, Jang YJ, Kim MK, Lee SM, Moon SY. Promising blood biomarkers for clinical use in Alzheimer\u2019s disease: a focused update. J Clin Neurol. 2022;18(4):401\u20139.","journal-title":"J Clin Neurol"},{"issue":"3","key":"405_CR8","first-page":"822","volume":"28","author":"SE Schindler","year":"2022","unstructured":"Schindler SE. Fluid biomarkers in dementia diagnosis. Continuum. 2022;28(3):822\u201333.","journal-title":"Continuum"},{"issue":"8","key":"405_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol. 2022;21(8):726\u201334.","journal-title":"Lancet Neurol"},{"issue":"1","key":"405_CR10","first-page":"205521731990129","volume":"6","author":"CS Simonsen","year":"2020","unstructured":"Simonsen CS, Flemmen H\u00d8, Lauritzen T, Berg-Hansen P, Moen SM, Celius EG. The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis. Mult Scler J Exp Transl Clin. 2020;6(1):205521731990129.","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"3","key":"405_CR11","doi-asserted-by":"publisher","first-page":"e0006122","DOI":"10.1128\/spectrum.00061-22","volume":"10","author":"T van Gorkom","year":"2022","unstructured":"van Gorkom T, Voet W, van Arkel GHJ, Heron M, Hoeve-Bakker BJA, Notermans DW, Thijsen SFT, Kremer K. Retrospective evaluation of various serological assays and multiple parameters for optimal diagnosis of lyme neuroborreliosis in a routine clinical setting. Microbiol Spectr. 2022;10(3):e0006122.","journal-title":"Microbiol Spectr."},{"issue":"1","key":"405_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2022.115657","volume":"103","author":"A Pietik\u00e4inen","year":"2022","unstructured":"Pietik\u00e4inen A, Backman I, Henningsson AJ, Hyt\u00f6nen J. Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serology. Diagn Microbiol Infect Dis. 2022;103(1): 115657.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"405_CR13","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3390\/diagnostics11112088","volume":"11","author":"M Lager","year":"2021","unstructured":"Lager M, Wilhelmsson P, Matussek A, Lindgren PE, Henningsson AJ. Molecular detection of borrelia bacteria in cerebrospinal fluid-optimisation of pre-analytical sample handling for increased analytical sensitivity. Diagnostics. 2021;11(11):2088.","journal-title":"Diagnostics"},{"issue":"2","key":"405_CR14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awab350","volume":"145","author":"M Schmitz","year":"2022","unstructured":"Schmitz M, Villar-Piqu\u00e9 A, Hermann P, Escaram\u00eds G, Calero M, Chen C, Kruse N, Cramm M, Golanska E, Sikorska B, Liberski PP, Pocchiari M, Lange P, Stehmann C, Sarros S, Mart\u00ed E, Baldeiras I, Santana I, \u017d\u00e1kov\u00e1 D, Mitrov\u00e1 E, Dong XP, Collins S, Poleggi A, Ladogana A, Mollenhauer B, Kovacs GG, Geschwind MD, S\u00e1nchez-Valle R, Zerr I, Llorens F. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases. Brain. 2022;145(2):700\u201312.","journal-title":"Brain"},{"issue":"4","key":"405_CR15","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/ijms23042051","volume":"23","author":"S Abu-Rumeileh","year":"2022","unstructured":"Abu-Rumeileh S, Barschke P, Oeckl P, Baiardi S, Mammana A, Mastrangelo A, Al Shweiki MR, Steinacker P, Ladogana A, Capellari S, Otto M, Parchi P. Prodynorphin and proenkephalin in cerebrospinal fluid of sporadic Creutzfeldt-Jakob disease. Int J Mol Sci. 2022;23(4):2051.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"405_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v14020276","volume":"14","author":"P Hermann","year":"2022","unstructured":"Hermann P, Haller P, Goebel S, Bunck T, Schmidt C, Wiltfang J, Zerr I. Total and phosphorylated cerebrospinal fluid tau in the differential diagnosis of sporadic creutzfeldt-jakob disease and rapidly progressive Alzheimer\u2019s disease. Viruses. 2022;14(2):1\u201314.","journal-title":"Viruses"},{"issue":"2","key":"405_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0014-4886(70)90234-7","volume":"28","author":"RWP Cutler","year":"1970","unstructured":"Cutler RWP, Murray JE, Cornick LR. Variations in protein permeability in different regions of the cerebrospinal fluid. Exp Neurol. 1970;28(2):257\u201365.","journal-title":"Exp Neurol"},{"issue":"3","key":"405_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0022-510X(78)90204-6","volume":"37","author":"B Weisner","year":"1978","unstructured":"Weisner B, Bernhardt W. Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid. Separate areas of reference. J Neurol Sci. 1978;37(3):205\u201314.","journal-title":"J Neurol Sci."},{"issue":"5","key":"405_CR19","first-page":"1162","volume":"46","author":"CS Bailey","year":"1985","unstructured":"Bailey CS, Higgins RJ. Comparison of total white blood cell count and total protein content of lumbar and cisternal cerebrospinal fluid of healthy dogs. Am J Vet Res. 1985;46(5):1162\u20135.","journal-title":"Am J Vet Res"},{"issue":"12","key":"405_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11940-019-0604-z","volume":"21","author":"AM Isaacs","year":"2019","unstructured":"Isaacs AM, Williams MA, Hamilton MG. Current update on treatment strategies for idiopathic normal pressure hydrocephalus. Curr Treat Options Neurol. 2019;21(12):65.","journal-title":"Curr Treat Options Neurol"},{"issue":"23","key":"405_CR21","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/WNL.0000000000002193","volume":"85","author":"JJ Halperin","year":"2015","unstructured":"Halperin JJ, Kurlan R, Schwalb JM, Cusimano MD, Gronseth G, Gloss D. Practice guideline: idiopathic normal pressure hydrocephalus: response to shunting and predictors of response: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2015;85(23):2063\u201371.","journal-title":"Neurology"},{"key":"405_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/CIA.S360736","volume":"17","author":"HM Said","year":"2022","unstructured":"Said HM, Kaya D, Yavuz I, Dost FS, Altun ZS, Isik AT. A comparison of cerebrospinal fluid beta-amyloid and tau in idiopathic normal pressure hydrocephalus and neurodegenerative dementias. Clin Interv Aging. 2022;17:467\u201377.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"405_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-022-00309-z","volume":"19","author":"H Lukkarinen","year":"2022","unstructured":"Lukkarinen H, Jeppsson A, Wikkels\u00f6 C, Blennow K, Zetterberg H, Constantinescu R, Remes AM, Herukka SK, Hiltunen M, Rauramaa T, N\u00e4gga K, Leinonen V, Tullberg M. Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients. Fluids Barriers CNS. 2022;19(1):11.","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"405_CR24","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3233\/JAD-210534","volume":"83","author":"G Bommarito","year":"2021","unstructured":"Bommarito G, Van De Ville D, Frisoni GB, Garibotto V, Ribaldi F, Stampacchia S, Assal F, Allali G, Griffa A. Alzheimer\u2019s disease biomarkers in idiopathic normal pressure hydrocephalus: linking functional connectivity and clinical outcome. J Alzheimers Dis. 2021;83(4):1717\u201328.","journal-title":"J Alzheimers Dis"},{"issue":"3 Suppl","key":"405_CR25","first-page":"S4","volume":"57","author":"N Relkin","year":"2005","unstructured":"Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3 Suppl):S4-16; discussion ii-v.","journal-title":"Neurosurgery."},{"issue":"5","key":"405_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3171\/2014.7.JNS14283","volume":"121","author":"T S\u00e6hle","year":"2014","unstructured":"S\u00e6hle T, Farahmand D, Eide PK, Tisell M, Wikkels\u00f6 C. A randomized controlled dual-center trial on shunt complications in idiopathic normal-pressure hydrocephalus treated with gradually reduced or \u201cfixed\u201d pressure valve settings. J Neurosurg. 2014;121(5):1257\u201363.","journal-title":"J Neurosurg"},{"issue":"4","key":"405_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/bmm.12.46","volume":"6","author":"M del Campo","year":"2012","unstructured":"del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, et al. Recommendations to standardize preanalytical confounding factors in Alzheimer\u2019s and Parkinson\u2019s disease cerebrospinal fluid biomarkers: an update. Biomark Med. 2012;6(4):419\u201330.","journal-title":"Biomark Med"},{"issue":"6","key":"405_CR28","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20199356","volume":"16","author":"JM Bader","year":"2020","unstructured":"Bader JM, Geyer PE, M\u00fcller JB, Strauss MT, Koch M, Leypoldt F, Koertvelyessy P, Bittner D, Schipke CG, Incesoy EI, et al. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease. Mol Syst Biol. 2020;16(6): e9356.","journal-title":"Mol Syst Biol"},{"issue":"12","key":"405_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.15252\/msb.20167357","volume":"12","author":"PE Geyer","year":"2016","unstructured":"Geyer PE, Wewer Albrechtsen NJ, Tyanova S, Grassl N, Iepsen EW, Lundgren J, Madsbad S, Holst JJ, Torekov SS, Mann M. Proteomics reveals the effects of sustained weight loss on the human plasma proteome. Mol Syst Biol. 2016;12(12):901.","journal-title":"Mol Syst Biol"},{"issue":"3","key":"405_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nmeth.2834","volume":"11","author":"NA Kulak","year":"2014","unstructured":"Kulak NA, Pichler G, Paron I, Nagaraj N, Mann M. Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat Methods. 2014;11(3):319\u201324.","journal-title":"Nat Methods"},{"issue":"12","key":"405_CR31","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1074\/mcp.RA117.000314","volume":"16","author":"R Bruderer","year":"2017","unstructured":"Bruderer R, Bernhardt OM, Gandhi T, Xuan Y, Sondermann J, Schmidt M, Gomez-Varela D, Reiter L. Optimization of experimental parameters in data-independent mass spectrometry significantly increases depth and reproducibility of results. Mol Cell Proteomics. 2017;16(12):2296\u2013309.","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"405_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/pr050300l","volume":"5","author":"SJ Callister","year":"2006","unstructured":"Callister SJ, Barry RC, Adkins JN, Johnson ET, Qian WJ, Webb-Robertson BJM, Smith RD, Lipton MS. Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J Proteome Res. 2006;5(2):277\u201386.","journal-title":"J Proteome Res"},{"issue":"5","key":"405_CR33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41587-021-01145-6","volume":"40","author":"A Santos","year":"2022","unstructured":"Santos A, Cola\u00e7o AR, Nielsen AB, Niu L, Strauss M, Geyer PE, Coscia F, Albrechtsen NJW, Mundt F, Jensen LJ, Mann M. A knowledge graph to interpret clinical proteomics data. Nat Biotechnol. 2022;40(5):692\u2013702.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"405_CR34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/cclm-2021-0651","volume":"60","author":"J Gobom","year":"2022","unstructured":"Gobom J, Parnetti L, Rosa-Neto P, Vyhnalek M, Gauthier S, Cataldi S, Lerch O, Laczo J, Cechova K, Clarin M, et al. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. Clin Chem Lab Med. 2022;60(2):207\u201319.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"405_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13195-018-0339-1","volume":"10","author":"L Gaetani","year":"2018","unstructured":"Gaetani L, H\u00f6glund K, Parnetti L, Pujol-Calderon F, Becker B, Eusebi P, Sarchielli P, Calabresi P, Di Filippo M, Zetterberg H, Blennow K. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimers Res Ther. 2018;10(1):8.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"405_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v070.i01","volume":"70","author":"J Josse","year":"2016","unstructured":"Josse J, Husson F. missMDA\u202f: a package for handling missing values in multivariate data analysis. J Stat Softw. 2016. https:\/\/doi.org\/10.18637\/jss.v070.i01.","journal-title":"J Stat Softw"},{"key":"405_CR37","volume-title":"Residuals and influence in regression","author":"RD Cook","year":"1982","unstructured":"Cook RD, Weisberg S. Residuals and influence in regression. New York: Chapman and Hall; 1982."},{"key":"405_CR38","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.neubiorev.2021.04.035","volume":"127","author":"F Michetti","year":"2021","unstructured":"Michetti F, Di Sante G, Clementi ME, Sampaolese B, Casalbore P, Volont\u00e9 C, Romano Spica V, Parnigotto PP, Di Liddo R, Amadio S, Ria F. Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders. Neurosci Biobehav Rev. 2021;127:446\u201358.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"405_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.neuchi.2021.01.001","volume":"67","author":"V Sapin","year":"2021","unstructured":"Sapin V, Gaulmin R, Aubin R, Walrand S, Coste A, Abbot M. Blood biomarkers of mild traumatic brain injury: state of art. Neurochirurgie. 2021;67(3):249\u201354.","journal-title":"Neurochirurgie"},{"issue":"3","key":"405_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/00207454.2020.1807979","volume":"132","author":"AC Arrais","year":"2022","unstructured":"Arrais AC, Melo LHMF, Norrara B, Almeida MAB, Freire KF, Melo AMMF, de Oliveira LC, Lima FOV, Engelberth RCGJ, de Souza Cavalcante J, et al. S100B protein: general characteristics and pathophysiological implications in the Central Nervous System. Int J Neurosci. 2022;132(3):313\u201321.","journal-title":"Int J Neurosci."},{"issue":"4","key":"405_CR41","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00018-020-03673-x","volume":"78","author":"E Angelopoulou","year":"2021","unstructured":"Angelopoulou E, Paudel YN, Piperi C. Emerging role of S100B protein implication in Parkinson\u2019s disease pathogenesis. Cell Mol Life Sci. 2021;78(4):1445\u201353.","journal-title":"Cell Mol Life Sci"},{"key":"405_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101654","volume":"79","author":"J Hawksworth","year":"2022","unstructured":"Hawksworth J, Fern\u00e1ndez E, Gevaert K. A new generation of AD biomarkers: 2019 to 2021. Ageing Res Rev. 2022;79: 101654.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"405_CR43","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.3390\/ijms23115877","volume":"23","author":"J Yang","year":"2022","unstructured":"Yang J, Hamade M, Wu Q, Wang Q, Axtell R, Giri S, Mao-Draayer Y. Current and future biomarkers in multiple sclerosis. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23115877.","journal-title":"Int J Mol Sci"},{"key":"405_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2022.06.004","volume":"101","author":"YY Wong","year":"2022","unstructured":"Wong YY, Wu CY, Yu D, Kim E, Wong M, Elez R, Zebarth J, Ouk M, Tan J, Liao J, et al. Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2022;101:119\u201328.","journal-title":"Parkinsonism Relat Disord"},{"key":"405_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.758182","volume":"16","author":"R Zanardini","year":"2022","unstructured":"Zanardini R, Saraceno C, Benussi L, Squitti R, Ghidoni R. Exploring neurofilament light chain and exosomes in the genetic forms of frontotemporal dementia. Front Neurosci. 2022;16: 758182.","journal-title":"Front Neurosci"},{"issue":"4","key":"405_CR46","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1227\/00006123-199510000-00009","volume":"37","author":"MA Rubalcava","year":"1995","unstructured":"Rubalcava MA, Sotelo J. Differences between ventricular and lumbar cerebrospinal fluid in hydrocephalus secondary to cysticercosis. Neurosurgery. 1995;37(4):668\u201371; discussion 671-2.","journal-title":"Neurosurgery"},{"issue":"1","key":"405_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12987-020-00205-4","volume":"17","author":"J Bergman","year":"2020","unstructured":"Bergman J, Svenningsson A, Liv P, Bergenheim T, Burman J. Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS. Fluids Barriers CNS. 2020;17(1):49.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"405_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12987-021-00256-1","volume":"18","author":"K Minta","year":"2021","unstructured":"Minta K, Jeppsson A, Brinkmalm G, Portelius E, Zetterberg H, Blennow K, Tullberg M, Andreasson U. Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2021;18(1):23.","journal-title":"Fluids Barriers CNS"},{"issue":"15","key":"405_CR49","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","volume":"80","author":"A Jeppsson","year":"2013","unstructured":"Jeppsson A, Zetterberg H, Blennow K, Wikkels\u00f8 C. Idiopathic normal-pressure hydrocephalus pathophysiology and diagnosis by CSF biomarkers. Neurology. 2013;80(15):1385\u201392.","journal-title":"Neurology"},{"issue":"3","key":"405_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091974","volume":"9","author":"OT Pyykk\u00f6","year":"2014","unstructured":"Pyykk\u00f6 OT, Lumela M, Rummukainen J, Nerg O, Sepp\u00e4l\u00e4 TT, Herukka SK, Koivisto AM, Alafuzoff I, Puli L, Savolainen S, et al. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus. PLoS ONE. 2014;9(3): e91974.","journal-title":"PLoS ONE"},{"issue":"6","key":"405_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010980","volume":"5","author":"SE Schutzer","year":"2010","unstructured":"Schutzer SE, Liu T, Natelson BH, Angel TE, Schepmoes AA, Purvine SO, Hixson KK, Lipton MS, Camp DG, Coyle PK, Smith RD, Bergquist J. Establishing the proteome of normal human cerebrospinal fluid. PLoS ONE. 2010;5(6): e10980.","journal-title":"PLoS ONE"},{"key":"405_CR52","volume":"2011","author":"V Leinonen","year":"2011","unstructured":"Leinonen V, Menon LG, Carroll RS, Dello Iacono D, Grevet J, J\u00e4\u00e4skel\u00e4inen JE, Black PM. Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. Int J Alzheimers Dis. 2011;2011: 312526.","journal-title":"Int J Alzheimers Dis"},{"key":"405_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-8454-5-9","volume":"5","author":"M Tullberg","year":"2008","unstructured":"Tullberg M, Blennow K, M\u00e5nsson JE, Fredman P, Tisell M, Wikkels\u00f6 C. Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus. Cerebrospinal Fluid Res. 2008;5:1\u20138.","journal-title":"Cerebrospinal Fluid Res"},{"issue":"5","key":"405_CR54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","volume":"116","author":"A \u00c5gren-Wilsson","year":"2007","unstructured":"\u00c5gren-Wilsson A, Lekman A, Sj\u00f6berg W, Rosengren L, Blennow K, Bergenheim AT, Malm J. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand. 2007;116(5):333\u20139.","journal-title":"Acta Neurol Scand"},{"key":"405_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-201182","volume":"80","author":"H Lukkarinen","year":"2021","unstructured":"Lukkarinen H, Tesseur I, Pemberton D, Van Der Ark P, Timmers M, Slemmon R, Janssens L, Streffer J, Van Nueten L, Bottelbergs A, et al. Time trends of cerebrospinal fluid biomarkers of neurodegeneration in idiopathic normal pressure hydrocephalus. J Alzheimer\u2019s Dis. 2021;80:1\u201314.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"6","key":"405_CR56","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/jemt.10303","volume":"60","author":"M Rothermundt","year":"2003","unstructured":"Rothermundt M, Peters M, Prehn JHM, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech. 2003;60(6):614\u201332.","journal-title":"Microsc Res Tech"},{"issue":"7","key":"405_CR57","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3390\/ijms19072035","volume":"19","author":"SR Chaudhry","year":"2018","unstructured":"Chaudhry SR, Hafez A, Rezai Jahromi B, Kinfe TM, Lamprecht A, Niemel\u00e4 M, Muhammad S. Role of damage associated molecular pattern molecules (DAMPs) in aneurysmal subarachnoid hemorrhage (aSAH). Int J Mol Sci. 2018;19(7):2035.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"405_CR58","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, Alvarez-Cerme\u00f1o JC, Andreasson U, Axelsson M, B\u00e4ckstr\u00f6m DC, et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76(9):1035\u201348.","journal-title":"JAMA Neurol."},{"issue":"9","key":"405_CR59","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1111\/ene.15428","volume":"29","author":"I Kmezic","year":"2022","unstructured":"Kmezic I, Samuelsson K, Finn A, Upate Z, Blennow K, Zetterberg H, Press R. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies. Eur J Neurol. 2022;29(9):2810\u201322.","journal-title":"Eur J Neurol"},{"issue":"3","key":"405_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0361-9230(03)00091-1","volume":"61","author":"A Petzold","year":"2003","unstructured":"Petzold A, Keir G, Lim D, Smith M, Thompson EJ. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull. 2003;61(3):281\u20135.","journal-title":"Brain Res Bull"},{"issue":"1","key":"405_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-019-0131-z","volume":"16","author":"A Benninghaus","year":"2019","unstructured":"Benninghaus A, Bal\u00e9dent O, Lokossou A, Castelar C, Leonhardt S, Radermacher K. Enhanced in vitro model of the CSF dynamics. Fluids Barriers CNS. 2019;16(1):11.","journal-title":"Fluids Barriers CNS"},{"issue":"JUN","key":"405_CR62","first-page":"154","volume":"8","author":"V Puy","year":"2016","unstructured":"Puy V, Zmudka-Attier J, Capel C, Bouzerar R, Serot JM, Bourgeois AM, Ausseil J, Bal\u00e9dent O. Interactions between flow oscillations and biochemical parameters in the cerebrospinal fluid. Front Aging Neurosci. 2016;8(JUN):154.","journal-title":"Front Aging Neurosci."},{"issue":"12","key":"405_CR63","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1177\/0271678X211039612","volume":"41","author":"A Requena-Jimenez","year":"2021","unstructured":"Requena-Jimenez A, Nabiuni M, Miyan JA. Profound changes in cerebrospinal fluid proteome and metabolic profile are associated with congenital hydrocephalus. J Cereb Blood Flow Metab. 2021;41(12):3400\u201314.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"405_CR64","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1095-6433(00)00180-X","volume":"125","author":"RS Seymour","year":"2000","unstructured":"Seymour RS. Model analogues in the study of cephalic circulation. Comp Biochem Physiol A Mol Integr Physiol. 2000;125(4):517\u201324.","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"2","key":"405_CR65","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.cbpa.2011.10.029","volume":"161","author":"HB Lillywhite","year":"2012","unstructured":"Lillywhite HB, Albert JS, Sheehy CM, Seymour RS. Gravity and the evolution of cardiopulmonary morphology in snakes. Comp Biochem Physiol A Mol Integr Physiol. 2012;161(2):230\u201342.","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"4","key":"405_CR66","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1113\/JP280318","volume":"599","author":"KI Iwasaki","year":"2021","unstructured":"Iwasaki KI, Ogawa Y, Kurazumi T, Imaduddin SM, Mukai C, Furukawa S, Yanagida R, Kato T, Konishi T, Shinojima A, Levine BD, Heldt T. Long-duration spaceflight alters estimated intracranial pressure and cerebral blood velocity. J Physiol. 2021;599(4):1067\u201381.","journal-title":"J Physiol"},{"issue":"3","key":"405_CR67","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/brainsci12030410","volume":"12","author":"FF Konen","year":"2022","unstructured":"Konen FF, Lange P, Wurster U, Jendretzky KF, Gingele S, M\u00f6hn N, S\u00fchs K-W, Stangel M, Skripuletz T, Schwenkenbecher P. The influence of the ventricular-lumbar gradient on cerebrospinal fluid analysis in serial samples. Brain Sci. 2022;12(3):410.","journal-title":"Brain Sci."},{"issue":"6","key":"405_CR68","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ca.21153","volume":"24","author":"M Edsbagge","year":"2011","unstructured":"Edsbagge M, Starck G, Zetterberg H, Ziegelitz D, Wikkelso C. Spinal cerebrospinal fluid volume in healthy elderly individuals. Clin Anat. 2011;24(6):733\u201340.","journal-title":"Clin Anat"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-022-00405-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T23:32:00Z","timestamp":1701732720000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-022-00405-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,21]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1186\/s12987-022-00405-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2048750\/v1","asserted-by":"object"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,21]]},"assertion":[{"value":"9 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients and the study was approved by the Ethical committee of the Capital Region of Denmark (H-19001474 and H-18046630). All animal experiments were performed according to the legislation for animal protection and care, animal permission no. 2016-15-0201-00957 approved by the Danish Animal Experiments Inspectorate and the Local Ethics Committee at The Department of Veterinary Clinical Sciences, University of Copenhagen. All animals were euthanized upon CSF collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Alector, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Passage Bio, Pinteon Therapeutics, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD\/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Ono Pharma, Pharmatrophix, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}